Production (Stage)
Actuate Therapeutics, Inc.
ACTU
$10.33
$0.232.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.32M | -6.45M | -5.97M | -6.57M | -8.30M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.13M | 1.20M | 1.22M | 1.24M | 685.80K |
| Change in Net Operating Assets | 568.10K | 477.00K | -4.40M | 2.66M | 2.36M |
| Cash from Operations | -4.62M | -4.77M | -9.15M | -2.67M | -5.25M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 200.00K | 1.00M | 4.50M |
| Total Debt Repaid | -- | 0.00 | -200.00K | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 23.96M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -133.50K | -109.40K | -1.64M | -43.00K | -142.80K |
| Cash from Financing | -133.50K | -109.40K | 22.32M | 957.00K | 4.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.75M | -4.88M | 13.17M | -1.72M | -890.40K |